488 related articles for article (PubMed ID: 28538950)
21. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
22. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
[TBL] [Abstract][Full Text] [Related]
23. Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery.
Muneoka Y; Akazawa K; Ishikawa T; Ichikawa H; Nashimoto A; Yabusaki H; Tanaka N; Kosugi SI; Wakai T
Int J Surg; 2016 Nov; 35():153-159. PubMed ID: 27664559
[TBL] [Abstract][Full Text] [Related]
24. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR
Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688
[TBL] [Abstract][Full Text] [Related]
25. The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Kim SG; Hwang SH
World J Surg Oncol; 2016 Apr; 14():102. PubMed ID: 27039375
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer: A Multicenter, Retrospective Study.
Jiang Y; Jin C; Yu H; Wu J; Chen C; Yuan Q; Huang W; Hu Y; Xu Y; Zhou Z; Fisher GA; Li G; Li R
Ann Surg; 2021 Dec; 274(6):e1153-e1161. PubMed ID: 31913871
[TBL] [Abstract][Full Text] [Related]
27. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
[TBL] [Abstract][Full Text] [Related]
28. The patterns and timing of recurrence after curative resection for gastric cancer in China.
Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
[TBL] [Abstract][Full Text] [Related]
29. Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer.
Jiang W; Wang H; Dong X; Yu X; Zhao Y; Chen D; Yan B; Cheng J; Zhuo S; Wang H; Yan J
JAMA Surg; 2024 May; 159(5):519-528. PubMed ID: 38416471
[TBL] [Abstract][Full Text] [Related]
30. [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer].
Cong X; Li S; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1144-1148. PubMed ID: 27781252
[TBL] [Abstract][Full Text] [Related]
31. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
32. Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy-A Chinese Multicenter Study.
Deng ZJ; Lu J; Nie RC; Fang JM; Chen XJ; Liu JJ; Li XZ; Chen YB; Huang CM; Lian L; Peng JS; Chen S
Ann Surg Oncol; 2022 Dec; 29(13):8214-8224. PubMed ID: 35798893
[TBL] [Abstract][Full Text] [Related]
33. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
[TBL] [Abstract][Full Text] [Related]
34. [Integration and analysis of associated data in surgical treatment of gastric cancer based on multicenter, high volume databases].
Wang W; Sun Z; Deng J; Wang Z; Zhou Z; Liang H; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):179-85. PubMed ID: 26831882
[TBL] [Abstract][Full Text] [Related]
35. Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter study.
Huang ZN; Desiderio J; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
BMC Gastroenterol; 2019 Dec; 19(1):205. PubMed ID: 31791240
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
[TBL] [Abstract][Full Text] [Related]
37. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of the current treatment status of gastric cancer in 636 patients].
Zhuang QX; Xu JM; Lin L; Ge FJ; Liu LJ; Wang Y; Zhao CH
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):316-20. PubMed ID: 22781048
[TBL] [Abstract][Full Text] [Related]
39. A novel prognosis prediction model after completion gastrectomy for remnant gastric cancer: Development and validation using international multicenter databases.
Lu J; Zheng ZF; Zhou JF; Xu BB; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Truty MJ; He QL; Huang CM
Surgery; 2019 Sep; 166(3):314-321. PubMed ID: 31221436
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
